Description

1,7,8-Indolizinetriol, 6-(Diethylamino)Octahydro-, Triacetate (Ester), 1S-(1.Alpha.,6.Beta.,7.Alpha.,8.Beta.,8A.Beta.)- is a complex, stereochemically defined indolizine derivative that serves as a critical synthetic intermediate and building block in advanced organic synthesis. Its value lies in its multifunctional structure, which provides multiple points for chemical modification, enabling the construction of sophisticated molecular architectures. This compound is essential for researchers and manufacturers in the pharmaceutical and agrochemical industries, particularly for developing novel active ingredients and exploring new chemical entities.

Application

• Pharmaceutical Intermediate: A key chiral building block for the synthesis of potential drug candidates, especially in alkaloid chemistry and the development of central nervous system (CNS) active compounds.
• Agrochemical Research: Used in the research and development of new pesticides and herbicides, leveraging its complex heterocyclic core.
• Organic Synthesis Reagent: Employed in academic and industrial R&D for constructing complex natural product analogs and exploring novel reaction pathways.
• Chemical Biology Probe: Serves as a precursor for labeled compounds or probes used to study biological mechanisms and enzyme interactions.
• Catalyst Ligand Development: Its structure can be modified to create novel chiral ligands for asymmetric catalysis.
• Fine Chemical Production: Used in the multi-step synthesis of high-value, specialty chemicals for various technological applications.

Basic Information

Product Name	1,7,8-Indolizinetriol, 6-(Diethylamino)Octahydro-, Triacetate (Ester), 1S-(1.Alpha.,6.Beta.,7.Alpha.,8.Beta.,8A.Beta.)-
CAS No.	156205-87-7
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	(+)-Swainsonine Triacetate; 1S-(1α,6β,7α,8β,8aβ)-1,7,8-Indolizinetriol, 6-(Diethylamino)octahydro-, Triacetate; 6-(Diethylamino)octahydro-1,7,8-indolizinetriol triacetate; Swainsonine Triacetate; 1S,6R,7R,8R,8aR-6-(Diethylamino)octahydroindolizine-1,7,8-triyl triacetate; Triacetylswainsonine; 156205-87-7; CAS 156205-87-7
EINECS	Contact for details

Quality Control

Our 1,7,8-Indolizinetriol, 6-(Diethylamino)Octahydro-, Triacetate (Ester) is produced under strict quality management protocols. Each batch undergoes rigorous analytical testing, including chiral purity verification and impurity profiling, to ensure it meets the exacting standards required for research and development applications. Certificates of Analysis (COA) detailing identity, purity (by HPLC), and specific rotation are available upon request to support your regulatory and quality assurance needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place. For long-term storage, maintaining the material at 2-8°C under an inert atmosphere is recommended to preserve stability and chiral integrity.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to reference spectrum
Identification (NMR)	Conforms to structure
Assay (HPLC)	≥ 95.0%
Chiral Purity (HPLC)	≥ 98.0% ee
Specific Rotation	Contact for details
Residual Solvents (GC)	Complies with ICH guidelines
Heavy Metals	< 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.